Close

Vice President visits the BIO Asia – Taiwan 2024 Exhibition

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

DFE Pharma appoints Sven Abend as new CEO

Goch, Germany - DFE Pharma, a global leader in pharma- and nutraceutical excipient...

At Pharmapack Europe, Schreiner MediPharm to Present Innovative Cap-Lock Label for Prefilled Syringes

Blauvelt, NY – Schreiner MediPharm, a Germany-based global provider of...

Aragen secures $100 Mn investment from Quadria Capital

Hyderabad, India and Singapore: Aragen, a globally renowned Contract Research,...

Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0

Paris: Pharmapack Europe & CPHI have outlined key trends for pharma in 2025,...

Taiwan Vice President Hsiao Mei-chin visited the BIO Asia–Taiwan 2024 Exhibition at the Nangang Exhibition Center (TaiNEX 1) this morning (28th) to learn about the latest technologies and equipment in the biotechnology field. She affirmed Taiwan’s strong biomedical capabilities and expressed her trust that the exhibition would assist Taiwanese biotechnology companies and institutions to better connect with their international counterparts.

Upon her arrival, the Vice President presented awards to the winners of this year’s Taiwan BIO Awards in the categories “Outstanding Company of the Year,” “Emerging Company of the Year,” “Startup of the Year,” and “Innovation of the Year.” She then toured the exhibition, including the “Contract Development and Manufacturing Services,” “Precision Medicine and Genetic Testing,” “International Pavilions,” “Government and Academic Research,” and “Industry-Academia Incubation” specialty zones, to witness the full biotechnology industry chain from research and development to finished product stage, in addition to taking in some of the latest emerging technologies and equipment. She praised Taiwan’s biomedical capabilities and looked forward to the exhibition attracting and encouraging exchanges and cooperation from key biotechnology companies both domestically and internationally.

The BIO Asia–Taiwan 2024 Exhibition is held at the Taipei Nangang Exhibition Center Hall 1 (TaiNEX 1) from July 26 to July 29. This year’s theme is “Global View, Asian Touch,” showcasing the breakthrough advancements in new drugs, innovative therapies, and regenerative medicine in Asia and Taiwan amidst the region’s rapid economic development.

The event was also attended by Minister of Health and Welfare Chiu Tai-yuan, BIO Asia-Taiwan 2024 Chairman Johnsee Lee, and Taiwan Bio Industry Organization Chairman Wu Chung-hsiun, among others.

Company: Taiwan Bio Industry Organization


Since its founding in 1989, the Taiwan Bio Industry Organization (TBIO) has been working closely with industry, government departments and academia to promote biotechnology and its contribution to Taiwan's economy and the health of its people. The more than 100 organizations and 3,000 individuals that make up TBIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors.

Send Enquiry for this story

By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.

Latest stories